Suzetrigine
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Suzetrigine is used to treat acute pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 30, 2025.
Suzetrigine is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $15.41 to $15.41 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$15.41 – $15.41
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SUZETRIGINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
JOURNAVX 50 MG TABLET | $15.4130 per EA | — |
JOURNAVX 50 MG TABLET | $15.4130 per EA | — |
Frequently Asked Questions
What is Suzetrigine used to treat?
Suzetrigine is used to treat acute pain, per the National Library of Medicine's MED-RT classification.
How many Suzetrigine products are on the market?
The Suzetrigine drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Suzetrigine?
NADAC reference prices for Suzetrigine range from $15.4130 to $15.4130 per EA.
Which manufacturers make Suzetrigine?
1 manufacturer lists Suzetrigine in NADAC. Ranked by number of NDCs, the largest are Vertex Pharmaceuticals Incorporated (2).